🎈 Up Big Today: Find today's biggest gainers (some over 50%!) with our free screenerTry Stock Screener

Creso Pharma hones in on pivotal Asian markets with Singapore and South Korea distribution deals

Published 15/05/2023, 10:23 am
© Reuters Creso Pharma hones in on pivotal Asian markets with Singapore and South Korea distribution deals

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) has doubled down on Asian markets after agreeing to expand its product range with Singapore-based distribution group Gotro Global.

Thanks to the deal, which expands the pharmaceutical stock’s footprint in Asia, Creso Pharma’s entire Green Goo animal care range is now stocked online through Gotro’s partner company, Happy Town Pets.

In a bid to further boost product visibility, a company-owned direct-to-consumer eCommerce channel is in development, slated to launch later this year.

Creso Pharma believes establishing a presence in Asia is fundamental to revenue growth, with several initiatives teed up to support the company’s expansion in this critical target market.

Expanding footprint in South Korea

In other news, Creso is also boosting its product reach in South Korea, where leading pet food provider Providence Animal Health Korea has agreed to distribute the Green Goo line alongside the Creso Pharma Switzerland animal care products.

The move comes after an early-stage A$217,400 purchase order for Creso’s anibidiol® product suite, underscoring confidence in consumer interest.

Creso is finalising product registration in Korea to support the Green Goo Animal First Aid range, with other products shortlisted for registration in the coming months.

Targeting sales growth in 2023

Creso Pharma CEO and managing director William Lay said the company’s latest initiatives reflected its momentum in the core Asian markets.

“The expanded distribution partnership in Singapore and South Korea provides Creso Pharma with a unique operating platform to drive further sales growth in 2023, with plenty of additional upside through pending product registrations and the recent launch of Sierra Sage Herbs product line into the Taiwanese animal healthcare market,” he stated.

“We look forward to providing additional updates on growth across the Asia markets over the coming months.”

Read more on Proactive Investors AU

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.